Guizhou Sanli Pharmaceutical Co.,Ltd.’s Net Profit Dropped 14% in First Three Quarters of 2022

Guizhou Sanli Pharmaceutical Co.,Ltd. (贵州三力制药股份有限公司) (603439.SH) reported a net profit of 95.4 million yuan in the first three quarters of 2022, down 14% year-on-year.

Meanwhile, the company posted 710.1 million yuan in revenue, up 15.6% year-on-year.

At the end of the reporting period, it had 1.6 billion yuan in total assets and 465.7 million yuan in total liabilities, with a liability-to-asset ratio of 29%.